Greenwich Biosciences, INC.
Based in CA
AI Overview
With $4.5M in lobbying spend across 22 quarterly filings, Greenwich Biosciences, INC is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2018 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $270K |
| 2019 | $1.7M |
| 2020 | $890K |
| 2021 | $1.6M |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Greenwich Biosciences, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Consumer Issues, Banking, Insurance and 1 more
Introduction of company and development of a FDA approved cannabinoid drug
SB 1008: Definition of CBD
SB 1276: Definition of authorized medical research
SB 1803: Definition of CBD
HR 331: Definition o
Introduction of company and development of a FDA approved cannabinoid drug
H.R. 2 - Agriculture Improvement Act of 2018 - FDA's jurisdiction over hemp-derived CBD products
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.